Compliance Rate

Compliance Rate 100.0%
Compliant submissions 1
Incompliant submissions 0
Total trials 1

My Organizations' Clinical Trials

Showing 1500 of 2228 entries
View as:

A Comparison of 18g of Tiotropium Inhalation Capsules Once Daily and Atrovent Metered Dose Inhaler (2 Puffs of 20g, 4 Times Daily) in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT00239434 Org: User:
Start: 06/30/03 End: 03/31/04 Due: 03/31/05

BI 6727 (Volasertib) Human ADME Trial in Various Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT01145885 Org: User:
Start: 06/30/10 End: 11/30/10 Due: 11/30/11

Follow on Study From RE-ALIGN

Phase: N/A Priority: Normal
NCT ID: NCT01505881 Org: User:
Start: 12/31/11 End: 06/30/13 Due: 06/30/14

A Study to Compare the Amount of Meloxicam in the Blood When it is Taken as Capsules or as Tablets

Phase: N/A Priority: Normal
NCT ID: NCT03684265 Org: User:
Start: 10/05/18 End: 11/06/18 Due: 11/06/19

Open Label Single Dose Phase I Trial of BI 201335 to Study Pharmacokinetics and Safety in Patients With Compensated Liver Cirrhosis

Phase: N/A Priority: Normal
NCT ID: NCT01909778 Org: User:
Start: 06/30/08 End: 10/31/08 Due: 10/31/09

24 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Black/African American Patients With Type 2 Diabetes Mellitus and Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02182830 Org: User:
Start: 07/25/14 End: 05/18/17 Due: 05/18/18

A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood

Phase: N/A Priority: Normal
NCT ID: NCT04619251 Org: User:
Start: 11/13/20 End: 08/03/21 Due: 08/03/22

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Doses of BI 10773 Tablets

Phase: N/A Priority: Normal
NCT ID: NCT01924767 Org: User:
Start: 07/31/07 End: 11/30/07 Due: 11/30/08

Antiviral Efficacy, Pharmacokinetics and Safety of BILN 2061 ZW in Patients With Chronic Hepatitis C Virus Infection

Phase: N/A Priority: Normal
NCT ID: NCT02226952 Org: User:
Start: 11/30/01 End: - Due: -

Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)

Phase: N/A Priority: Normal
NCT ID: NCT02999178 Org: User:
Start: 01/17/17 End: 08/12/19 Due: 08/12/20

A Trial Comparing MICARDIS® (Telmisartan) and COZAAR® (Losartan) in Patients With Mild-to-Moderate Hypertension Using Ambulatory Blood Pressure Monitoring (ABPM)

Phase: N/A Priority: Normal
NCT ID: NCT02200640 Org: User:
Start: 03/31/00 End: - Due: -

Relative Bioavailability of Tiotropium and Salmeterol After Inhalation of a Fixed Combined Dose Compared to Monocomponents in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02254174 Org: User:
Start: 03/31/06 End: - Due: -

Acetylsalicylic Acid (ASA) + Paracetamol + Caffeine Combination Compared With ASA + Paracetamol as Well as ASA, Paracetamol, and Caffeine in Headache Patients

Phase: N/A Priority: Normal
NCT ID: NCT02183688 Org: User:
Start: 09/30/98 End: - Due: -

Relative Bioavailability of BI 691751 Administered With and Without Food to Healthy Male Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02175238 Org: User:
Start: 07/31/14 End: 10/31/14 Due: 10/31/15

Afatinib in Subjects With Kidney Dysfunction

Phase: N/A Priority: Normal
NCT ID: NCT02096718 Org: User:
Start: 05/31/14 End: 12/31/14 Due: 12/31/15

Observational Study of Adherence to LABA / LAMA in Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01937390 Org: User:
Start: 11/06/11 End: 10/22/16 Due: 10/22/17

A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

Phase: N/A Priority: Normal
NCT ID: NCT04147247 Org: User:
Start: 12/23/19 End: 05/27/21 Due: 05/27/22

Clinical Outcomes and Healthcare Cost and Resource Utilization (HCRU) in Patients With Type 2 Diabetes and Cardiovascular Disease on 2nd Line Empagliflozin Versus 2nd Line Sulfonylureas

Phase: N/A Priority: Normal
NCT ID: NCT05102071 Org: User:
Start: 11/01/21 End: 06/15/22 Due: 06/15/23

Study to Investigate the Relative Bioavailability of Ibuprofen in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02183012 Org: User:
Start: 08/31/02 End: - Due: -

Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00967447 Org: User:
Start: 02/01/09 End: - Due: -

Study to Assess the Influence of Three Different α-antagonists and Placebo on the Extent of Weekly Phenylephrine-induced Mydriasis at Three Different Concentrations of Phenylephrine in Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02266537 Org: User:
Start: 11/30/05 End: - Due: -

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Phase: N/A Priority: Normal
NCT ID: NCT02832037 Org: User:
Start: 07/25/16 End: 01/29/20 Due: 01/29/21

Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food

Phase: N/A Priority: Normal
NCT ID: NCT02229838 Org: User:
Start: 07/31/99 End: - Due: -

Single Rising Doses of BI 655064 in Healthy Chinese and Japanese Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01917916 Org: User:
Start: 08/05/13 End: 05/14/14 Due: 05/14/15

Relative Bioavailability of Pioglitazone After Co-administration With Different Doses of BI 10773 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02172235 Org: User:
Start: 04/30/10 End: - Due: -